Schär Celebrates Celiac Awareness Month with Commitment to Education, Support, and Innovation

Schär Steps Up Celiac Awareness Month: Leading the Charge in Gluten-Free Innovation and Community Support

Swedesboro, NJ / May 2024 / This May, Schär, one of the world’s leading brands in gluten-free food innovation, gears up to celebrate Celiac Awareness Month with a range of activities aimed at raising awareness, supporting the celiac disease community, and showcasing their dedication to advancing research and education in the field of gluten-related disorders.

Celiac Awareness Month is an important time for individuals and organizations to come together to increase understanding and support for those living with celiac disease. Schär is proud to join initiatives led by the Celiac Disease Foundation and the National Celiac Association, including the "Shine a Light on Celiac Disease" campaign and the iCureCeliac Patient Registry campaign. These efforts aim to shine a spotlight on celiac disease, raise funds for research, and provide resources for those affected by the condition.

In addition to supporting these initiatives, Schär is actively involved in Digestive Disease Week (DDW), held in May in Washington, D.C. This premier conference brings together gastroenterologists, researchers, and other healthcare professionals to discuss the latest advancements in GI nutrition and celiac disease research. Schär's products will be featured at the Celiac Disease Foundation booth, allowing attendees to sample their delicious and nutritious gluten-free offerings.

Celiac Awareness Month holds special significance for Schär, a company dedicated to providing delicious and safe gluten-free options. For Schär, it's an opportunity to raise awareness about celiac disease and showcase their ongoing commitment to supporting the celiac community and driving innovation in gluten-free food.

At DDW, Schär will be attending the annual Society for the Study of Celiac Disease meeting, where he will engage with leading experts and researchers in the field. This event provides a valuable opportunity for Schär to stay abreast of the latest developments in celiac disease research and to contribute to discussions on advancing diagnosis, treatment, and management of the condition.

As part of their commitment to education and support, Schär will be hosting product giveaways throughout the month, providing individuals with the opportunity to try their high-quality gluten-free products. These giveaways not only offer delicious gluten-free options but also serve as a reminder of Schär's dedication to making gluten-free living easier and more enjoyable for everyone.

In addition to their participation in Celiac Awareness Month activities, Schär remains focused on innovation, constantly striving to develop new and improved gluten-free products that meet the diverse needs and preferences of their customers. Through partnerships with leading organizations and ongoing research and development efforts, Schär continues to lead the way in gluten-free food innovation.

About Schär

For more than 100 years, Dr. Schär's mission has been to improve the lives of people with special nutritional needs. Dr. Schär USA, Inc. is committed to providing great-tasting gluten-free food to the celiac, gluten-sensitive sensitive and IBS communities—offering a safe, flavorful, and high-quality line of gluten-free products. Schär has over 20,000 doors in the US and retailers including Walmart, Kroger, Sprouts, Whole Foods, ShopRite, Stop & Shop, and many more. The full portfolio of products spans from bread, cookies, candy, and crackers to frozen items, including puff pastry dough and croissants! The new soy-free Artisan Baker Breads further solidifies the commitment to trust among consumers with food allergies.

Forward-Looking Statements

This release contains forward-looking statements regarding future operating and financial performance, product development, market position, and business strategy and objectives. These statements are based on current expectations of future events and are inherently subject to uncertainty. Actual results could vary materially from expectations and projections due to various factors. For a further list and description of these risks, uncertainties, and other factors, please refer to Dr. Schär's filings with the SEC. Information in this release is as of the dates indicated herein, and Dr. Schär does not undertake to update any of the information contained in these materials, except as required by law.